The Female Health Company Receives Order for 3.5 Million FC2 Female Condoms for Distribution at 2010 World Cup
CHICAGO, June 2, 2010 - The Female Health Company (NASDAQ-CM: FHCO) announced that it has fulfilled an order for 3.5 million FC2 Female Condoms to be distributed for HIV/AIDS prevention to attendees at the 2010 World Cup. The 2010 World Cup will take place in The Republic of South Africa from June 11, 2010 to July 11, 2010.
The month-long 2010 World Cup, which offers three million tickets to the games, is expected to flood the country with visitors. This event has been targeted as an opportunity to provide critical protection against transmission of sexually transmitted infections (STI's), including HIV/AIDS.
O. B. Parrish, Chairman and CEO of FHC, praised the action stating, "Providing FC2 Female Condoms for the World Cup 2010 demonstrates a commitment to supporting HIV/AIDS prevention efforts. This commitment is particularly critical in light of the increasing numbers of females affected by AIDS." UNAIDS reports that worldwide, 33.2 million people, 15.4 million of which are women aged 15 years and older, are now living with HIV. WHO recently indicated HIV/AIDs is now the leading cause of death among women 15 to 44 years of age worldwide. The Global Coalition on Women and AIDS, a UNAIDS Initiative, is calling for more money in AIDS programs that work for women including closing the funding gap for the female condom and microbicides development."
About The Female Health Company
The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC2 Female Condom® (FC2), which is available in about 100 countries around the world. The Company owns certain worldwide rights to the FC2 Female Condom®, including patents that have been issued in Europe, Canada, Australia, South Africa and Japan and pending in various countries. The FC2 Female Condom® is the only available FDA-approved product controlled by a woman that offers dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. The World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies.
"Safe Harbor" statement under the Private Securities Litigation Reform Action of 1995:
The statements in this release which are not historical facts are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchanges Commission filings. Actual events affecting the Company and the impact of such events on the Company's operations may vary from this currently anticipated.
For more information about the Female Health Company visit the Company's website at http://www.femalehealth.com and http://www.femalecondom.org. If you would like to be added to the Company's e-mail alert list, please send an e-mail to FHCInvestor@femalehealthcompany.com
William R. Gargiulo, Jr.
Source: Female Health Company
"Reproduced with permission - Female Health Company "
Female Health Company